The bad berka heart rhythm registry (2B2R) is a prospective, single-center observational cohort evaluating safety, efficacy, and outcomes in patients undergoing arrhythmia therapy or CIED implantation at the heart center bad berka
NCT ID NCT07020910
First seen Sep 09, 2026 · Last updated Sep 09, 2026
Summary
The Bad Berka Heart Rhythm Registry (2B2R) is a prospective, single-center observational cohort designed to systematically collect and analyze data of patients undergoing cardiac arrhythmia therapy as well as implantation of cardiac electronic devices (CIEDs) at the Heart Center Bad Berka. The register aims to evaluate procedural safety, acute and long-term efficacy, and clinical outcomes across a broad spectrum of arrhythmias and interventional strategies, including novel technologies such as pulsed field ablation (PFA) and conduction system pacing. The registry is intended to generate real-world evidence to support clinical decision-making, identify predictors of outcomes, and contribute to quality assurance and innovation in the field of cardiac electrophysiology.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 5,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2024
- Expected to finish
-
Aug 2034
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with Cardiac Arrhythmias or at Risk for the Development of Cardiac Arrhythmias Undergoing Drug-Therapy or Interventional Procedures at the Heart Center Bad Berka
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years * At risk of or with documented cardiac arrhythmia undergoing medical or interventional therapy at the Heart Center Bad Berka * Informed consent obtained Exclusion Criteria: * Inability or unwillingness to provide informed consent * Participation in another interventional trial that precludes registry inclusion
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiac arrhythmias are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Zentralklinik Bad Berka
RECRUITINGBad Berka, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may spot deadly heart rhythms before they strike
- Can a Stick-On AI patch replace wires for heart monitoring after surgery?
- Can early rhythm control stop hidden heart rhythms from becoming dangerous?
- New antibiotic pouch aims to stop infections in heart device patients
- Which heart patch works best? study puts six to the test
- New heart camera catheter tested in 500 patients